Company intelligence / Profile preview

Pulsify Medical

Leuven, Flemish Brabant/Brabant Flamand, Belgiumpulsify-medical.com ↗

Ownership: Private
Development stage: Other

Overview

The company has developed a wearable ultrasound patch capable of continuous, direct, and non-invasive cardiac performance monitoring. As of mid–2024, the device has been tested on healthy volunteers to validate its accuracy and usability. Commercial launch targeted for around late 2024 or early 2025. No published clinical trial results yet.

Therapeutic areas: CardiovascularOther
Modalities: Device (Wearable ultrasound patch)
Industry: Physiological Monitoring

Partnerships

imec (R&D partner/spin-off originator)KU Leuven / UZ Leuven – academic partners/spin-off originators/investors

Beyond the preview

Go deeper on Pulsify Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulsify Medical.

Explore the full profile